Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L K Harding
W H Thomson

Showing results (71-80 of 188) with videos related to

Pageof 19
Sort By:
European Journal of Nuclear Medicine|July 10, 1999
Radiation exposure of the families of outpatients treated with radioiodine (iodine-131) for hyperthyroidismS F Barrington, M J O'Doherty, A G Kettle, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 1, 1977
Carrier detection in X-linked recessive (Duchenne) muscular dystrophy: pyruvate kinase isoenzymes and creatine phosphokinase in serum and blood cellsI Smith, W H Thomson
Metabolism: Clinical and Experimental|February 1, 1978
X-linked recessive (Duchenne) muscular dystrophy (DMD) and purine metabolism: effects of oral allopurinol and adenylateW H Thomson, I Smith
Lancet (London, England)|May 3, 1975
Letter: Serum enzyme assays with commercial kitsI Smith, W H Thomson
Nuclear Medicine Communications|August 1, 1993
Nuclear medicine and the pregnant patientP J Mountford, L K Harding
Nuclear Medicine Communications|June 1, 1988
Pattern of radiopharmaceutical administration to patients between 1982 and 1986S R Hesslewood, L K Harding
Nuclear Medicine Communications|November 1, 1989
Breast milk--still more data requiredP J Mountford, L K Harding
The International Journal of Applied Radiation and Isotopes|May 1, 1972
113 in albumin aggregates for lung scanningL K Harding, D H Keeling
Nuclear Medicine Communications|January 14, 1999
An interactive session: how do you do it?L K Harding, N B Smith
Nuclear Medicine Communications|November 1, 1992
Computed tomographic practice and dosimetry: implications for nuclear medicineP J Mountford, L K Harding
Pageof 19

Showing results (71-80 of 188) with videos related to

Sort By:
Pageof 19
European Journal of Nuclear Medicine|July 10, 1999
Radiation exposure of the families of outpatients treated with radioiodine (iodine-131) for hyperthyroidismS F Barrington, M J O'Doherty, A G Kettle, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 1, 1977
Carrier detection in X-linked recessive (Duchenne) muscular dystrophy: pyruvate kinase isoenzymes and creatine phosphokinase in serum and blood cellsI Smith, W H Thomson
Metabolism: Clinical and Experimental|February 1, 1978
X-linked recessive (Duchenne) muscular dystrophy (DMD) and purine metabolism: effects of oral allopurinol and adenylateW H Thomson, I Smith
Lancet (London, England)|May 3, 1975
Letter: Serum enzyme assays with commercial kitsI Smith, W H Thomson
Nuclear Medicine Communications|August 1, 1993
Nuclear medicine and the pregnant patientP J Mountford, L K Harding
Nuclear Medicine Communications|June 1, 1988
Pattern of radiopharmaceutical administration to patients between 1982 and 1986S R Hesslewood, L K Harding
Nuclear Medicine Communications|November 1, 1989
Breast milk--still more data requiredP J Mountford, L K Harding
The International Journal of Applied Radiation and Isotopes|May 1, 1972
113 in albumin aggregates for lung scanningL K Harding, D H Keeling
Nuclear Medicine Communications|January 14, 1999
An interactive session: how do you do it?L K Harding, N B Smith
Nuclear Medicine Communications|November 1, 1992
Computed tomographic practice and dosimetry: implications for nuclear medicineP J Mountford, L K Harding
Pageof 19